ARTIVION, INC. (AORT)

Latest Insider Confidence Score

2026Q1

51.1
Bullish

Company insider confidence (by quarter)

2015Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Mackin James P CEO 862,835 Dec 3, 2025
Holloway Jean F SVP, General Counsel 163,408 Dec 4, 2025
Berry Lance A CFO 153,431 Mar 10, 2025
Capps Scott B VP, Clinical Research 153,203 Mar 15, 2021
Bevevino Daniel J — 150,061 May 27, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 2, 2026 Mar 4, 2026 Horton Amy VP, Chief Accounting Officer Sell 83.8 +6,574 4.96% ✗ $34K
Mar 2, 2026 Mar 4, 2026 Holloway Jean F SVP, General Counsel Sell 92.5 +14,990 8.81% ✗ $485.7K
Mar 2, 2026 Mar 4, 2026 Stanton Marshall S. SVP, Clinical & MD Affair Sell 95.0 +19,689 48.73% ✗ $81.2K
Mar 2, 2026 Mar 4, 2026 Davis John E Chief Commercial Officer Sell 95.0 +24,272 11.75% ✗ $172.7K
Mar 2, 2026 Mar 4, 2026 Berry Lance A CFO Sell 95.0 +34,558 19.61% ✗ $238.6K
Mar 2, 2026 Mar 4, 2026 Mackin James P CEO Sell 97.5 +99,061 11.68% ✗ $675.7K
Mar 2, 2026 Mar 3, 2026 Horton Amy VP, Chief Accounting Officer Sell 51.3 -641 -0.48% ✗ $24.4K
Mar 2, 2026 Mar 3, 2026 Stanton Marshall S. SVP, Clinical & MD Affair Sell 42.5 -1,513 -3.61% ✗ $57.5K
Mar 2, 2026 Mar 3, 2026 Mackin James P CEO Sell 40.0 -14,911 -1.73% ✗ $567K
Mar 2, 2026 Mar 3, 2026 Holloway Jean F SVP, General Counsel Sell 42.5 -2,183 -1.27% ✗ $83K
Mar 2, 2026 Mar 3, 2026 Berry Lance A CFO Sell 42.5 -5,178 -2.85% ✗ $196.9K
Mar 2, 2026 Mar 3, 2026 Davis John E Chief Commercial Officer Sell 42.5 -2,784 -1.33% ✗ $105.9K
Feb 23, 2026 Feb 25, 2026 Horton Amy VP, Chief Accounting Officer Sell 82.5 +3,097 2.38% ✗ $94.7K
Feb 23, 2026 Feb 25, 2026 Stanton Marshall S. SVP, Clinical & MD Affair Sell 42.5 -3,682 -8.07% ✗ $136K
Feb 23, 2026 Feb 25, 2026 Holloway Jean F SVP, General Counsel Sell 90.0 +15,338 9.77% ✗ $175.3K
Feb 23, 2026 Feb 25, 2026 Mackin James P CEO Sell 95.0 +62,132 7.76% ✗ $1.3M
Feb 23, 2026 Feb 25, 2026 Berry Lance A CFO Sell 97.5 +28,016 18.26% ✗ $347.3K
Feb 23, 2026 Feb 25, 2026 Davis John E Chief Commercial Officer Sell 90.0 +14,590 7.49% ✗ $215.9K
Jun 30, 2025 Jan 28, 2026 Stanton Marshall S. SVP, Clinical & MD Affair Neutral 77.5 +850 1.90% ✗ -
Jun 30, 2025 Jan 28, 2026 Davis John E Chief Commercial Officer Neutral 60.0 +874 0.45% ✗ -
Jun 30, 2025 Jan 28, 2026 Holloway Jean F SVP, General Counsel Neutral 67.5 +857 0.55% ✗ -
Dec 15, 2025 Dec 17, 2025 Davis John E Chief Commercial Officer Sell 22.5 -5,000 -2.51% ✗ $225.6K
Dec 8, 2025 Dec 9, 2025 Horton Amy VP, Chief Accounting Officer Sell 42.5 -4,572 -3.40% ✗ $203.1K
Dec 3, 2025 Dec 4, 2025 Mackin James P CEO Sell 32.5 -30,921 -3.72% ✓ $1.4M
Dec 3, 2025 Dec 4, 2025 Holloway Jean F SVP, General Counsel Sell 20.0 -7,315 -4.48% ✗ $331.4K
Dec 2, 2025 Dec 3, 2025 Mackin James P CEO Sell 32.5 -30,921 -3.72% ✓ $1.4M
Dec 1, 2025 Dec 2, 2025 Horton Amy VP, Chief Accounting Officer Neutral 37.5 -750 -0.55% ✗ -
Nov 21, 2025 Nov 24, 2025 Stanton Marshall S. SVP, Clinical & MD Affair Sell 17.5 -47,376 -19.70% ✗ $2.1M
Nov 20, 2025 Nov 24, 2025 Stanton Marshall S. SVP, Clinical & MD Affair Sell 20.0 -15,276 -10.22% ✗ $674.8K
Nov 18, 2025 Nov 19, 2025 Hoff Elizabeth A Director Sell 22.5 -4,200 -13.38% ✗ $189.4K
Nov 14, 2025 Nov 18, 2025 Holloway Jean F SVP, General Counsel Sell 35.0 -12,787 -3.77% ✓ $576.5K
Nov 14, 2025 Nov 18, 2025 Davis John E Chief Commercial Officer Sell 35.0 -12,787 -3.12% ✓ $574.4K
Nov 17, 2025 Nov 18, 2025 Horton Amy VP, Chief Accounting Officer Sell 20.0 -6,000 -4.24% ✗ $274.4K
Nov 13, 2025 Nov 14, 2025 Horton Amy VP, Chief Accounting Officer Sell 42.5 -3,482 -2.40% ✗ $159.7K
Nov 13, 2025 Nov 14, 2025 Davis John E Chief Commercial Officer Sell 40.0 -6,563 -3.20% ✗ $301K
Nov 13, 2025 Nov 14, 2025 Mackin James P CEO Sell 37.5 -34,210 -4.10% ✗ $1.6M
Nov 13, 2025 Nov 14, 2025 Holloway Jean F SVP, General Counsel Sell 40.0 -5,761 -3.41% ✗ $264.2K
Nov 13, 2025 Nov 14, 2025 Stanton Marshall S. SVP, Clinical & MD Affair Sell 42.5 -4,993 -8.10% ✗ $229K
Nov 10, 2025 Nov 12, 2025 Holloway Jean F SVP, General Counsel Sell 40.0 -12,960 -3.69% ✗ $593.9K
Nov 10, 2025 Nov 12, 2025 Mackin James P CEO Sell 40.0 -17,580 -2.06% ✗ $784.4K
Nov 10, 2025 Nov 12, 2025 Davis John E Chief Commercial Officer Sell 42.5 -3,373 -1.62% ✗ $150.5K
Nov 10, 2025 Nov 12, 2025 Horton Amy VP, Chief Accounting Officer Sell 42.5 -1,789 -1.22% ✗ $79.8K
Nov 10, 2025 Nov 12, 2025 Stanton Marshall S. SVP, Clinical & MD Affair Sell 42.5 -2,566 -4.00% ✗ $114.5K
Aug 27, 2025 Aug 28, 2025 Stanton Marshall S. SVP, Clinical & MD Affair Sell 20.0 -18,200 -22.09% ✗ $801.2K
Aug 25, 2025 Aug 26, 2025 Holloway Jean F SVP, General Counsel Sell 20.0 -10,000 -5.49% ✗ $443.7K
Aug 15, 2025 Aug 19, 2025 Mackin James P CEO Sell 20.0 -12,500 -1.44% ✗ $529K
Aug 12, 2025 Aug 14, 2025 Holloway Jean F SVP, General Counsel Sell 17.5 -23,356 -11.95% ✗ $1M
Aug 12, 2025 Aug 14, 2025 Davis John E Chief Commercial Officer Sell 20.0 -10,802 -4.92% ✗ $471.8K
Aug 8, 2025 Aug 11, 2025 Horton Amy VP, Chief Accounting Officer Sell 30.0 -7,992 -5.17% ✓ $307.6K
Jun 17, 2025 Jun 18, 2025 Stanton Marshall S. SVP, Clinical & MD Affair Sell 17.5 -15,000 -18.94% ✓ $442.5K
Jun 13, 2025 Jun 16, 2025 Stanton Marshall S. SVP, Clinical & MD Affair Sell 12.5 -26,132 -24.81% ✓ $743.1K
May 27, 2025 May 27, 2025 Holloway Jean F SVP, General Counsel Sell 20.0 -8,748 -4.67% ✗ $253.7K
May 23, 2025 May 27, 2025 SEMEDO ANTHONY B. Director Sell 22.5 -2,600 -6.19% ✗ $74K
May 22, 2025 May 27, 2025 SEMEDO ANTHONY B. Director Neutral 90.0 +6,325 17.74% ✗ -
May 22, 2025 May 27, 2025 Borgstrom Marna P Director Neutral 90.0 +6,325 14.79% ✗ -
May 22, 2025 May 27, 2025 BEVEVINO DANIEL J Director Neutral 82.5 +6,325 4.40% ✗ -
May 22, 2025 May 27, 2025 ACKERMAN THOMAS F Director Neutral 82.5 +6,325 4.41% ✗ -
May 22, 2025 May 27, 2025 Salveson Jon W Director Neutral 85.0 +6,325 5.12% ✗ -
May 22, 2025 May 27, 2025 Hoff Elizabeth A Director Neutral 90.0 +6,325 25.24% ✗ -
May 22, 2025 May 27, 2025 Burbank Jeffrey H Director Neutral 90.0 +6,325 13.32% ✗ -
May 22, 2025 May 27, 2025 Bullock James Director Neutral 90.0 +6,325 10.15% ✗ -
May 23, 2025 May 27, 2025 SEMEDO ANTHONY B. Director Sell 22.5 -2,600 -7.29% ✗ $74K
May 21, 2025 May 21, 2025 Holloway Jean F SVP, General Counsel Sell 20.0 -9,926 -5.03% ✗ $287.9K
May 9, 2025 May 12, 2025 Stanton Marshall S. SVP, Clinical & MD Affair Sell 20.0 -10,548 -9.10% ✗ $307.3K
Mar 11, 2025 Mar 12, 2025 Holloway Jean F SVP, General Counsel Sell 26.3 -18,020 -8.37% ✓ $425.5K
Mar 11, 2025 Mar 12, 2025 Davis John E Chief Commercial Officer Sell 30.0 -15,100 -6.74% ✓ $356.5K
Mar 6, 2025 Mar 10, 2025 Mackin James P CEO Sell 87.5 +27,262 1.06% ✓ $2.2M
Mar 6, 2025 Mar 10, 2025 Horton Amy VP, Chief Accounting Officer Sell 86.3 +9,213 6.70% ✗ $26K
Mar 6, 2025 Mar 10, 2025 Berry Lance A CFO Sell 95.0 +43,191 39.18% ✗ $121.8K
Mar 6, 2025 Mar 10, 2025 Davis John E Chief Commercial Officer Sell 95.0 +23,036 12.46% ✗ $64.9K
Mar 6, 2025 Mar 10, 2025 Stanton Marshall S. SVP, Clinical & MD Affair Sell 91.3 +17,637 17.95% ✗ $39.8K
Mar 6, 2025 Mar 10, 2025 Holloway Jean F SVP, General Counsel Sell 95.0 +23,369 13.53% ✗ $52.7K
Mar 5, 2025 Mar 6, 2025 Holloway Jean F SVP, General Counsel Sell 43.8 -472 -0.27% ✗ $11.9K
Mar 5, 2025 Mar 5, 2025 SEMEDO ANTHONY B. Director Buy 90.0 +2,100 6.15% ✗ $53.1K
Feb 28, 2025 Mar 4, 2025 Stanton Marshall S. SVP, Clinical & MD Affair Neutral 90.0 +18,398 23.04% ✗ -
Feb 28, 2025 Mar 4, 2025 Mackin James P CEO Neutral 90.0 +98,524 14.84% ✗ -
Feb 28, 2025 Mar 4, 2025 Horton Amy VP, Chief Accounting Officer Neutral 82.5 +6,297 4.80% ✗ -
Feb 28, 2025 Mar 4, 2025 Holloway Jean F SVP, General Counsel Neutral 90.0 +23,416 15.63% ✗ -
Feb 28, 2025 Mar 4, 2025 Davis John E Chief Commercial Officer Neutral 90.0 +24,301 15.13% ✗ -
Feb 28, 2025 Mar 4, 2025 Berry Lance A CFO Neutral 90.0 +34,435 45.43% ✗ -
Feb 24, 2025 Feb 26, 2025 Horton Amy VP, Chief Accounting Officer Sell 42.5 -3,323 -2.47% ✗ $90.7K
Feb 24, 2025 Feb 26, 2025 Mackin James P CEO Sell 37.5 -42,156 -5.97% ✗ $1.2M
Feb 24, 2025 Feb 26, 2025 Holloway Jean F SVP, General Counsel Sell 42.5 -5,335 -3.44% ✗ $145.7K
Feb 24, 2025 Feb 26, 2025 Davis John E Chief Commercial Officer Sell 42.5 -6,457 -3.86% ✗ $176.3K
Feb 24, 2025 Feb 26, 2025 Berry Lance A CFO Sell 42.5 -3,259 -4.12% ✗ $89K
Feb 24, 2025 Feb 26, 2025 Stanton Marshall S. SVP, Clinical & MD Affair Sell 42.5 -4,687 -5.54% ✗ $128K
Jun 30, 2024 Jan 30, 2025 Davis John E Chief Commercial Officer Neutral 67.5 +1,398 0.84% ✗ -
Jun 30, 2024 Jan 30, 2025 Stanton Marshall S. SVP, Clinical & MD Affair Neutral 77.5 +1,236 1.48% ✗ -
Jun 30, 2024 Jan 30, 2025 Holloway Jean F SVP, General Counsel Neutral 67.5 +1,272 0.83% ✗ -
Dec 12, 2024 Dec 13, 2024 Horton Amy VP, Chief Accounting Officer Neutral 37.5 -1,100 -0.81% ✗ -
Dec 11, 2024 Dec 12, 2024 Holloway Jean F SVP, General Counsel Sell 22.5 -8,070 -4.98% ✗ $243.1K
Dec 6, 2024 Dec 10, 2024 Horton Amy VP, Chief Accounting Officer Sell 42.5 -4,425 -3.16% ✗ $128.6K
Dec 6, 2024 Dec 9, 2024 Horton Amy VP, Chief Accounting Officer Sell 42.5 -4,329 -3.09% ✗ $128.4K
Dec 4, 2024 Dec 4, 2024 GREEN ANDREW M VP Regulatory Sell 20.0 -7,618 -18.53% ✓ $228.5K
Oct 1, 2024 Oct 2, 2024 Horton Amy VP, Chief Accounting Officer Sell 26.3 -12,430 -8.16% ✓ $325.4K
Aug 26, 2024 Aug 27, 2024 Holloway Jean F SVP, General Counsel Sell 22.5 -3,167 -1.92% ✗ $84.1K
Aug 16, 2024 Aug 19, 2024 Getz Matthew A VP, Human Resources Sell 22.5 -9,420 -21.64% ✗ $238.4K
Aug 15, 2024 Aug 16, 2024 Holloway Jean F SVP, General Counsel Sell 22.5 -2,383 -1.42% ✗ $61.4K
Aug 13, 2024 Aug 15, 2024 SEMEDO ANTHONY B. Director Sell 22.5 -9,709 -22.13% ✗ $242.6K
May 30, 2024 Jun 3, 2024 ACKERMAN THOMAS F Director Neutral 82.5 +6,289 4.58% ✗ -